CDH1 and ovarian cancer: In one such experiment, miR-506-3p was incorporated in 1,2-Dioleoyl-sn-Glycero-3-Phosphatidylcholine (DOPC) nanoliposomes and delivered to ovarian cancer in a mouse model, which resulted in MET with increased E-cadherin expression and decreased tumor growth [18].